Insider Selling: Imperva CFO Sells 15,000 Shares of Stock (IMPV)
Imperva (NASDAQ:IMPV) CFO Terrence J. Schmid sold 15,000 shares of the stock on the open market in a transaction that occurred on Thursday, August 21st. The stock was sold at an average price of $29.07, for a total transaction of $436,050.00. Following the completion of the sale, the chief financial officer now directly owns 3,437 shares of the company’s stock, valued at approximately $99,914. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.
Shares of Imperva (NASDAQ:IMPV) traded up 1.00% on Friday, hitting $29.24. 229,691 shares of the company’s stock traded hands. Imperva has a one year low of $18.40 and a one year high of $67.12. The stock has a 50-day moving average of $24.95 and a 200-day moving average of $35.31. The company’s market cap is $774.7 million.
Imperva (NASDAQ:IMPV) last released its earnings data on Thursday, July 31st. The company reported ($0.25) EPS for the quarter, beating the Thomson Reuters consensus estimate of ($0.41) by $0.16. The company had revenue of $38.40 million for the quarter, compared to the consensus estimate of $34.41 million. During the same quarter in the prior year, the company posted ($0.10) earnings per share. The company’s quarterly revenue was up 22.7% on a year-over-year basis. On average, analysts predict that Imperva will post $-0.95 earnings per share for the current fiscal year.
A number of research firms have recently commented on IMPV. Analysts at Deutsche Bank reiterated a “hold” rating on shares of Imperva in a research note on Tuesday. They now have a $30.00 price target on the stock. Analysts at Piper Jaffray initiated coverage on shares of Imperva in a research note on Tuesday, August 12th. They set a “neutral” rating and a $29.00 price target on the stock. Six investment analysts have rated the stock with a hold rating and five have given a buy rating to the company’s stock. Imperva currently has an average rating of “Hold” and a consensus price target of $37.70.
Imperva, Inc (NASDAQ:IMPV) is engaged in providing data security solutions focused on providing visibility and control over business data across systems within the data center.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.